Cargando…

“Artificial Intelligence” for Pharmacovigilance: Ready for Prime Time?

There is great interest in the application of ‘artificial intelligence’ (AI) to pharmacovigilance (PV). Although US FDA is broadly exploring the use of AI for PV, we focus on the application of AI to the processing and evaluation of Individual Case Safety Reports (ICSRs) submitted to the FDA Adverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ball, Robert, Dal Pan, Gerald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112277/ https://www.ncbi.nlm.nih.gov/pubmed/35579808 http://dx.doi.org/10.1007/s40264-022-01157-4

Ejemplares similares

Pharmacovigilance Considerations for Biosimilars in the USA
por: Grampp, Gustavo, et al.
Publicado: (2015)

French Pharmacovigilance Public System and COVID-19 Pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Artificial Intelligence and the Future of the Drug Safety Professional
por: Danysz, Karolina, et al.
Publicado: (2018)

Computational Approaches for Pharmacovigilance Signal Detection: Toward Integrated and Semantically-Enriched Frameworks
por: Koutkias, Vassilis G., et al.
Publicado: (2015)

Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems
por: Shrestha, Sunil, et al.
Publicado: (2021)

Polygenic risk score for embryo selection—not ready for prime time
por: Polyakov, Alex, et al.
Publicado: (2022)

The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization
por: Smith, Meredith Y., et al.
Publicado: (2016)

Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets
por: Anjum, Rani Lill, et al.
Publicado: (2022)

What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects
por: van Eekeren, Rike, et al.
Publicado: (2018)

Are Seizure Detection Devices Ready for Prime Time?
por: Van Ness, Paul C.
Publicado: (2019)

Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?
por: Vass, Caroline M., et al.
Publicado: (2017)

Management of incidental nodules in lung cancer screening: ready for prime-time?
por: Kanellakis, Nikolaos I., et al.
Publicado: (2019)

Is STN Neuromodulation of Focal Motor Seizures Ready for Prime Time?
por: King-Stephens, David
Publicado: (2021)

Black Swan Events and Intelligent Automation for Routine Safety Surveillance
por: Kjoersvik, Oeystein, et al.
Publicado: (2022)

The Metaverse in Urology: Ready for Prime Time. The ESUT, ERUS, EULIS, and ESU Perspective
por: Checcucci, Enrico, et al.
Publicado: (2022)

Artificial intelligence in pharmacovigilance: Practical utility
por: Murali, Kotni, et al.
Publicado: (2019)

Pharmacovigilance of antimalarial treatment in Africa: is it possible?
por: Talisuna, Ambrose O, et al.
Publicado: (2006)

Artificial intelligence—the future is now
por: Trolice, Mark P., et al.
Publicado: (2021)

Artificial nervous systems—A new paradigm for artificial intelligence
por: Narcross, Fredric
Publicado: (2021)

Commentary: Automated Diagnosis and Gleason Grading of Prostate Cancer – Are Artificial Intelligence Systems Ready for Prime Time?
por: Parwani, Anil V.
Publicado: (2019)

The Whole Price of Vancomycin: Toxicities, Troughs, and Time
por: Jeffres, Meghan N.
Publicado: (2017)

Collecting data on organizational structures of trauma centers: the CAFE web service
por: Brochhausen, Mathias, et al.
Publicado: (2020)

Resuming elective surgical services in times of COVID-19 infection
por: Coimbra, Raul, et al.
Publicado: (2020)

Recent Improvements in Marathon Run Times Are Likely Technological, Not Physiological
por: Muniz-Pardos, Borja, et al.
Publicado: (2021)

It’s Time to Change Direction on Agility Research: a Call to Action
por: Young, Warren, et al.
Publicado: (2021)

Managing Healthcare Budgets in Times of Austerity: The Role of Program Budgeting and Marginal Analysis
por: Mitton, Craig, et al.
Publicado: (2014)

Time to Differentiate Postactivation “Potentiation” from “Performance Enhancement” in the Strength and Conditioning Community
por: Prieske, Olaf, et al.
Publicado: (2020)

Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate?
por: Monteleone, Giovanni, et al.
Publicado: (2022)

Decision-Making in Artificial Intelligence: Is It Always Correct?
por: Kim, Hun-Sung
Publicado: (2019)

The Potential Dangers of Artificial Intelligence for Radiology and Radiologists
por: Chu, Linda C., et al.
Publicado: (2020)

Ensuring Product Quality, Consistency and Patient Supply over Time for a Large-Volume Biologic: Experience with Remicade(®)
por: Melsheimer, Richard, et al.
Publicado: (2018)

Prime Time for Artificial Intelligence in Interventional Radiology
por: Seah, Jarrel, et al.
Publicado: (2022)

An overview of digital readiness in dentistry - are we ready?
por: Dickenson, Andrew, et al.
Publicado: (2022)

Key challenges for delivering clinical impact with artificial intelligence
por: Kelly, Christopher J., et al.
Publicado: (2019)

Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources
por: Liang, Likeng, et al.
Publicado: (2022)

Industry Perspective on Artificial Intelligence/Machine Learning in Pharmacovigilance
por: Kassekert, Raymond, et al.
Publicado: (2022)

The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence -assisted antiseizure medication selection ready for prime time?
por: Gunasekera, Charlene L., et al.
Publicado: (2023)

REBOA: is it ready for prime time?
por: Doucet, Jay, et al.
Publicado: (2017)

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
por: Ference, Brian A., et al.
Publicado: (2017)

The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence
por: Xue, Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mnbe1gddvbnb45ksi6fome98pr